Immunogenicity MasterClass - EU edition

An important topic for complex therapeutics like Biologics, Biopharmaceuticals, Biosimilars & ATMPs Wanted for different kind of vaccines, unwanted for a variety of complex Large Biological Entities (LBEs)
 

27-29 January, 2025, Virtual

Time Zone : UTC/GMT+1 /CET

Overview

Main Benefits or Value Propositions of Attending This Event:

1. Comprehensive Understanding of In Vitro Immunogenicity:
Attendees will gain a thorough foundation in the principles and applications of in vitro immunogenicity testing, from basic concepts to advanced techniques. This will include regulatory expectations, risk mitigation, and the use of predictive assays for immune responses.

2. Practical Troubleshooting Skills:
The training will focus on common challenges in immunogenicity testing, such as assay variability, sensitivity, and false positives. Attendees will learn how to address these issues through real world case studies, improving the reliability of their assays.

3. Guidance:
Participants will benefit from interactive sessions that include practical examples and troubleshooting strategies. This exposure will help them apply their new knowledge directly to their projects and processes.

How Attendees Knowledge or Skills Will Be Improved:
1. Enhanced Assay Development Proficiency:
By understanding the nuances of in vitro assays and how to optimize them, attendees will be better equipped to design and implement more accurate immunogenicity tests.

2. Improved Regulatory and Compliance Understanding:
Participants will leave with a stronger grasp of the regulatory landscape around immunogenicity testing, enabling them to meet global guidelines more effectively and streamline submissions.

3. Data Analysis and Interpretation:
Attendees will learn how to interpret complex immunogenicity data, recognize potential immune responses early in drug development, and minimize risks associated with immunogenicity in biopharmaceuticals.

What Sets This Event Apart:
1. Focus on Troubleshooting and Problem Solving:
Unlike many events that focus solely on theoretical knowledge, this training emphasizes problem-solving. Attendees will actively engage in identifying and addressing challenges, making them better prepared for real-world applications.

2. Tailored for Different Expertise Levels:
Whether youre new to in vitro immunogenicity or have years of experience, the training is structured to benefit a wide range of professionals.

3. Confidence:
By attending, participants will not only enhance their technical skills but also gain the confidence to tackle complex immunogenicity challenges, making them valuable assets in their organizations.

#masterclass     #pharmaonlinemasterclass      #glceurope      #globalleadingconferences       #immunogenicity

RECOMMENDATION

Who should attend?

-Analysts, Senior analysts

-Team leads

-Managers

-Scientists

-Associates/Research associates

-Quality associates